Tom King, Baron King of Bridgwater

Tom King, Baron King of Bridgwater

Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Former Jets center Nick Mangold dies at 41 from kidney disease, leaving behind a legacy of excellence and toughness.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • Former Jets center Nick Mangold dies at 41 from kidney disease, leaving behind a legacy of excellence and toughness.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Tom King, Baron King of Bridgwater